An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
NCT ID: NCT00939783
Last Updated: 2012-11-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
649 participants
INTERVENTIONAL
2009-09-30
2010-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dimebon 20 mg TID
10 mg TID for Week 1, followed by 20 mg TID for remainder of study
Dimebon
Tablet for oral administration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dimebon
Tablet for oral administration
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medivation, Inc.
INDUSTRY
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Mobile, Alabama, United States
Pfizer Investigational Site
Northport, Alabama, United States
Pfizer Investigational Site
Little Rock, Arkansas, United States
Pfizer Investigational Site
Oceanside, California, United States
Pfizer Investigational Site
San Diego, California, United States
Pfizer Investigational Site
Santa Rosa, California, United States
Pfizer Investigational Site
Pueblo, Colorado, United States
Pfizer Investigational Site
Hockessin, Delaware, United States
Pfizer Investigational Site
Bradenton, Florida, United States
Pfizer Investigational Site
Brooksville, Florida, United States
Pfizer Investigational Site
Clearwater, Florida, United States
Pfizer Investigational Site
Daytona Beach, Florida, United States
Pfizer Investigational Site
Fort Myers, Florida, United States
Pfizer Investigational Site
Fort Walton Beach, Florida, United States
Pfizer Investigational Site
Maitland, Florida, United States
Pfizer Investigational Site
Melbourne, Florida, United States
Pfizer Investigational Site
Naples, Florida, United States
Pfizer Investigational Site
Ocala, Florida, United States
Pfizer Investigational Site
Orlando, Florida, United States
Pfizer Investigational Site
Plant City, Florida, United States
Pfizer Investigational Site
Port Charlotte, Florida, United States
Pfizer Investigational Site
St. Petersburg, Florida, United States
Pfizer Investigational Site
St. Petersburg, Florida, United States
Pfizer Investigational Site
Tampa, Florida, United States
Pfizer Investigational Site
Atlanta, Georgia, United States
Pfizer Investigational Site
Burr Ridge, Illinois, United States
Pfizer Investigational Site
Elk Grove Village, Illinois, United States
Pfizer Investigational Site
Elkhart, Indiana, United States
Pfizer Investigational Site
Evansville, Indiana, United States
Pfizer Investigational Site
Fort Wayne, Indiana, United States
Pfizer Investigational Site
Greenfield, Indiana, United States
Pfizer Investigational Site
Prairie Village, Kansas, United States
Pfizer Investigational Site
Wichita, Kansas, United States
Pfizer Investigational Site
Lake Charles, Louisiana, United States
Pfizer Investigational Site
New Orleans, Louisiana, United States
Pfizer Investigational Site
Shreveport, Louisiana, United States
Pfizer Investigational Site
Hyannis, Massachusetts, United States
Pfizer Investigational Site
Flowood, Mississippi, United States
Pfizer Investigational Site
Olive Branch, Mississippi, United States
Pfizer Investigational Site
Springfield, Missouri, United States
Pfizer Investigational Site
Great Falls, Montana, United States
Pfizer Investigational Site
Eatontown, New Jersey, United States
Pfizer Investigational Site
Oakhurst, New Jersey, United States
Pfizer Investigational Site
Toms River, New Jersey, United States
Pfizer Investigational Site
Albuquerque, New Mexico, United States
Pfizer Investigational Site
Amherst, New York, United States
Pfizer Investigational Site
Buffalo, New York, United States
Pfizer Investigational Site
Buffalo, New York, United States
Pfizer Investigational Site
Orchard Park, New York, United States
Pfizer Investigational Site
Syracuse, New York, United States
Pfizer Investigational Site
Charlotte, North Carolina, United States
Pfizer Investigational Site
Raleigh, North Carolina, United States
Pfizer Investigational Site
Winston-Salem, North Carolina, United States
Pfizer Investigational Site
Fargo, North Dakota, United States
Pfizer Investigational Site
Fargo, North Dakota, United States
Pfizer Investigational Site
Cincinnati, Ohio, United States
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States
Pfizer Investigational Site
Portland, Oregon, United States
Pfizer Investigational Site
Altoona, Pennsylvania, United States
Pfizer Investigational Site
Beaver, Pennsylvania, United States
Pfizer Investigational Site
Bridgeville, Pennsylvania, United States
Pfizer Investigational Site
Grove City, Pennsylvania, United States
Pfizer Investigational Site
Indiana, Pennsylvania, United States
Pfizer Investigational Site
Norristown, Pennsylvania, United States
Pfizer Investigational Site
Scotland, Pennsylvania, United States
Pfizer Investigational Site
Upper Saint Clair, Pennsylvania, United States
Pfizer Investigational Site
Charleston, South Carolina, United States
Pfizer Investigational Site
Greer, South Carolina, United States
Pfizer Investigational Site
Murrells Inlet, South Carolina, United States
Pfizer Investigational Site
North Charleston, South Carolina, United States
Pfizer Investigational Site
Orangeburg, South Carolina, United States
Pfizer Investigational Site
Sioux Falls, South Dakota, United States
Pfizer Investigational Site
Franklin, Tennessee, United States
Pfizer Investigational Site
Knoxville, Tennessee, United States
Pfizer Investigational Site
Carrollton, Texas, United States
Pfizer Investigational Site
Fort Worth, Texas, United States
Pfizer Investigational Site
Fort Worth, Texas, United States
Pfizer Investigational Site
Grand Prairie, Texas, United States
Pfizer Investigational Site
Lake Jackson, Texas, United States
Pfizer Investigational Site
Williamsburg, Virginia, United States
Pfizer Investigational Site
Kirkland, Washington, United States
Pfizer Investigational Site
Spokane, Washington, United States
Pfizer Investigational Site
Charleston, West Virginia, United States
Pfizer Investigational Site
La Crosse, Wisconsin, United States
Pfizer Investigational Site
Calgary, Alberta, Canada
Pfizer Investigational Site
Medicine Hat, Alberta, Canada
Pfizer Investigational Site
Victoria, British Columbia, Canada
Pfizer Investigational Site
Saint John, New Brunswick, Canada
Pfizer Investigational Site
Bay Roberts, Newfoundland and Labrador, Canada
Pfizer Investigational Site
Kentville, Nova Scotia, Canada
Pfizer Investigational Site
Pictou, Nova Scotia, Canada
Pfizer Investigational Site
Burlington, Ontario, Canada
Pfizer Investigational Site
London, Ontario, Canada
Pfizer Investigational Site
Sarnia, Ontario, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
L'Ancienne-Lorette, Quebec, Canada
Pfizer Investigational Site
Québec, Quebec, Canada
Pfizer Investigational Site
Québec, Quebec, Canada
Pfizer Investigational Site
Saint-Jean-sur-Richelieu, Quebec, Canada
Pfizer Investigational Site
Saint-Léonard, Quebec, Canada
Pfizer Investigational Site
Sherbrooke, Quebec, Canada
Pfizer Investigational Site
Cayey, , Puerto Rico
Pfizer Investigational Site
Cidra, , Puerto Rico
Pfizer Investigational Site
San Juan, , Puerto Rico
Pfizer Investigational Site
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B1451029
Identifier Type: -
Identifier Source: org_study_id